NCT03752333
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03752333
Title Trial of Pembrolizumab in Cancer of Unknown Primary (CUPem)
Acronym CUPem
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Hammersmith Hospital - Imperial College Healthcare NHS Trust Hammersmith London W12 0HS United Kingdom Details
Gastrointestinal Units, The Royal Marsden NHS Foundation Trust (Sutton and Chelsea) Sutton Surrey United Kingdom Details
Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field